BlackRock, Inc. 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 3:45 pm Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
BlackRock Inc. BLK |
1,821,966 5.500% |
1,821,966 (New Position) |
Filing |